Liver diseases have become a major health threat across Europe, and the face of European hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral hepatitis B, the increasingly widespread unhealthy use of alcohol, the epidemic of obesity, and undiagnosed or untreated liver disease in migrant populations. Consequently, Europe is facing a looming syndemic, in which socioeconomic and health inequities combine to adversely affect liver disease prevalence, outcomes, and opportunities to receive care. In addition, the COVID-19 pandemic has magnified pre-existing challenges to uniform implementation of policies and equity of access to care in Europe, arising from national borders and the cultural and historical h...
Liver disease in the UK stands out as the one glaring exception to the vast improvements made during...
The World Health Organization ‘Global Health Sector Strategy on Viral Hepatitis 2016–2021’ aimed at ...
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and ESCMID publish...
Liver diseases have become a major health threat across Europe, and the face of European hepatology ...
Key messages• Liver disease is now the second leading cause of years of working life lost in Europe,...
Background & Aims: The burden of liver disease in Europe continues to grow. We aimed to describ...
The past 30 years have witnessed major progress in the knowledge and management of liver disease, ye...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
SummaryTo survey the burden of liver disease in Europe and its causes 260 epidemiological studies pu...
The COVID-19 pandemic has presented a serious challenge to the hepatology community, particularly he...
International audienceBy 2040, deaths from chronic viral hepatitis worldwide are projected to exceed...
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In th...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87185/1/j.1365-2893.2011.01499.x.pd
With hepatitis B and C, the European region is confront-ing a devastating epidemic that seemingly ha...
Liver disease in the UK stands out as the one glaring exception to the vast improvements made during...
The World Health Organization ‘Global Health Sector Strategy on Viral Hepatitis 2016–2021’ aimed at ...
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and ESCMID publish...
Liver diseases have become a major health threat across Europe, and the face of European hepatology ...
Key messages• Liver disease is now the second leading cause of years of working life lost in Europe,...
Background & Aims: The burden of liver disease in Europe continues to grow. We aimed to describ...
The past 30 years have witnessed major progress in the knowledge and management of liver disease, ye...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
SummaryTo survey the burden of liver disease in Europe and its causes 260 epidemiological studies pu...
The COVID-19 pandemic has presented a serious challenge to the hepatology community, particularly he...
International audienceBy 2040, deaths from chronic viral hepatitis worldwide are projected to exceed...
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In th...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87185/1/j.1365-2893.2011.01499.x.pd
With hepatitis B and C, the European region is confront-ing a devastating epidemic that seemingly ha...
Liver disease in the UK stands out as the one glaring exception to the vast improvements made during...
The World Health Organization ‘Global Health Sector Strategy on Viral Hepatitis 2016–2021’ aimed at ...
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and ESCMID publish...